Legal Representation for Surgical Mesh Victims in California, New York, Texas and all the United States

Avaulta, manufactured by C.R. Bard, is one of dozens of transvaginal mesh implants that are marketed as solutions to pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Transvaginal mesh devices such as the Avaulta have grown in popularity, with approximately 75,000 women receiving a mesh implant in 2011. Despite its popularity, in recent months the device has been under scrutiny by the FDA, surgeons, and patients. C.R. Bard pulled the Avaulta from the shelves on July 1, 2012 due to the FDA’s request for more clinical trials.

The $5.5 Million Avaulta Lawsuit

On July 23, 2012, a 53 year-old-woman and her husband were awarded $5.5 million in damages in a lawsuit filed against C.R. Bard. The plaintiff, Christine Scott, had received an Avaulta transvaginal mesh implant to treat her incontinence, only to undergo eight revision surgeries to remedy the damages caused by the Avaulta implant. Even with multiple revision surgeries, Scott may still require additional surgery until all of the harmful mesh has been excised from her tissue.

What is a Transvaginal Mesh?

Approximately 40 percent of women suffer from pelvic organ prolapse, and 11 percent of that number opts for surgical treatment. Although surgery is widely used to treat POP, many times the results are not permanent, requiring one or two more revision surgeries. The transvaginal mesh appeared to produce better results by reinforcing the vaginal wall and preventing organ drooping with a strong surgical mesh. However, not only has the FDA concluded the procedure to be not anymore effective than surgery done without a mesh implant, the mesh may pose serious health risks unique to the implant.

Avaulta Complications

Scott reported complications immediately after surgery; suffering cuts in her colon and tissue growth through the surgical mesh. Mesh erosion is the most common and consistently reported complication caused by transvaginal mesh implants. Because of the porous nature of surgical mesh, over time, the mesh can extrude through the vaginal wall causing:

  • Chronic pain
  • Pain during vaginal intercourse (dyspareunia)
  • Internal bleeding
  • Urinary problems
  • Infection
  • Recurrent prolapse/incontinence

Taking Your Rights Seriously

If you have been a victim of a transvaginal mesh injury, be sure to consult a lawyer about your rights to compensation. Over 3,500 adverse event reports have been filed with the FDA, and major medical device manufacturers such as C.R. Bard are currently facing hundreds of lawsuits filed by women seeking compensation for their injuries. As of July 1, 2012, there were over 740 cases filed against the Avaulta manufacturer, with hundreds more expected to follow.

Secure Your Rightful Compensation

Scott’s successful lawsuit has set a precedent, establishing consumer rights against corporate interests. For Avaulta patients harmed by the defective device, a prompt consultation with a knowledgeable product liability lawyer can help ensure C.R. Bard is held fully accountable for the damages incurred as a result of Avaulta complications. In order to protect your rightful compensation, contact a knowledgeable product liability attorney today. Whether you are in California or in New York, we have attorneys who can help you and provide the answers you need today.

Leave a Reply